Cite
Zapatero-Belinchón FJ, Moeller R, Lasswitz L, et al. Fluvastatin mitigates SARS-CoV-2 infection in human lung cells. iScience. 2021;24(12):103469doi: 10.1016/j.isci.2021.103469.
Zapatero-Belinchón, F. J., Moeller, R., Lasswitz, L., van Ham, M., Becker, M., Brogden, G., Rosendal, E., Bi, W., Carriquí-Madroñal, B., Islam, K., Lenman, A., Gunesch, A. P., Kirui, J., Pietschmann, T., Överby, A. K., Jänsch, L., & Gerold, G. (2021). Fluvastatin mitigates SARS-CoV-2 infection in human lung cells. iScience, 24(12), 103469. https://doi.org/10.1016/j.isci.2021.103469
Zapatero-Belinchón, Francisco J, et al. "Fluvastatin mitigates SARS-CoV-2 infection in human lung cells." iScience vol. 24,12 (2021): 103469. doi: https://doi.org/10.1016/j.isci.2021.103469
Zapatero-Belinchón FJ, Moeller R, Lasswitz L, van Ham M, Becker M, Brogden G, Rosendal E, Bi W, Carriquí-Madroñal B, Islam K, Lenman A, Gunesch AP, Kirui J, Pietschmann T, Överby AK, Jänsch L, Gerold G. Fluvastatin mitigates SARS-CoV-2 infection in human lung cells. iScience. 2021 Dec 17;24(12):103469. doi: 10.1016/j.isci.2021.103469. Epub 2021 Nov 18. PMID: 34812415; PMCID: PMC8599137.
Copy
Download .nbib